Smoking cessation: an overview of treatment options with a focus on varenicline (Q36982688)

17 August 2017

1 reference

title

Smoking cessation: an overview of treatment options with a focus on varenicline (English)

1 reference

17 August 2017

1 reference

Nicole M Stack

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

1 reference

17 August 2017

page(s)

1550-1557

1 reference

Results of a smoking cessation clinic in community pharmacy practice

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Development and implementation of a smoking cessation clinic in community pharmacy practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Effectiveness of a pharmacist-based smoking-cessation program and its impact on quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

The pharmacist's role in smoking cessation counseling: perceptions of users of nonprescription nicotine replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Nicotine Nasal Spray for Smoking Cessation: Pattern of Use, Side Effects, Relief of Withdrawal Symptoms, and Cotinine Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Efficacy of a nicotine lozenge for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Pharmacotherapy of smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Effect of nonnicotine pharmacotherapy on smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Bupropion and other non-nicotine pharmacotherapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

The biology of nicotine dependence: from the 1988 Surgeon General's Report to the present and into the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Pharmacotherapy for nicotine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

Randomized Comparative Trial of Nicotine Polacrilex, a Transdermal Patch, Nasal Spray, and an Inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.11.1550

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.11.1550

1 reference

17 August 2017

1 reference